Serviços Personalizados
Journal
Artigo
Espanhol (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO
Links relacionados
Similares em
SciELO
Compartilhar
Permalink
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
versão impressa ISSN 2225-5109versão On-line ISSN 2227-4731
Resumo
FARFAN-CHAVEZ, Gabriel Luis e PEREZ-ACUNA MEDINA, Alexandra Katherine. Modified antituberculosis regimen due to hepatotoxicity caused by Pyrazinamide: Case report. Rev. Cuerpo Med. HNAAA [online]. 2023, vol.16, n.1, pp.134-137. Epub 27-Mar-2023. ISSN 2225-5109. http://dx.doi.org/10.35434/rcmhnaaa.2023.161.1645.
Introduction:
Tuberculosis is one of the 10 leading causes of death worldwide. In 2020, it caused 1.5 million deaths. It is estimated that it reached 10.0 million new cases during the same year.
Case of report:
93-year-old male, history of pulmonary TB 15 years ago and current TB contact. He presented dyspnea and pleuritic pain for 4 months. Thoracocentesis concludes exudate, pleural biopsy compatible with non-caseating granulomatous pleurisy. Receive antituberculosis regimen, developing hepatic RAFA. Pharmacological challenge is performed to design a new treatment scheme. Patient manages to recover. It is concluded that the management of tuberculosis should be individualized.
Palavras-chave : pleural tuberculosis; pleural effusion; adverse effects; antitubercular drugs.
